Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Wearable Injectors Market Report 2026 (8th Edition) Featuring Analysis of BD, Enable Injections, Insulet, Medtronic, Tandem Diabetes Care, West Pharmaceutical Services, and Ypsomed

globenewswire.com

Wearable Injectors Market Report 2026 (8th Edition) Featuring Analysis of BD, Enable Injections, Insulet, Medtronic, Tandem Diabetes Care, West Pharmaceutical Services, and Ypsomed Dublin, April 21, 2026 (GLOBE NEWSWIRE) -- The "Wearable Injectors Market (8th Edition): Distribution by Type of Device, Degree of Automation, Usability, Therapeutic Area, and Geographical Regions - Trends and Forecast Till 2035" has been added to ResearchAndMarkets.com's offering.

The global wearable injectors market is set to expand from USD 6.8 billion to USD 13.0 billion by 2035, with a CAGR of 7.4% during this forecast period. This growth is propelled by the increasing instances of chronic illnesses such as autoimmune diseases, cardiovascular conditions, and cancer. The industry is witnessing an innovative shift toward patient-centered solutions that enhance treatment adherence and outcomes through wearable injectors.

Prominent players in the industry, like BD, are developing products like the BD LibertasTM wearable injector, designed for discreet, efficient subcutaneous delivery of complex biologics. These injectors facilitate at-home care, increasing patient comfort and reducing the likelihood of needlestick injuries.

Market Trends and Technological Advancements

Wearable injectors are becoming essential in home-care environments, offering advanced features like AI-driven health monitoring and seamless integration with mobile applications. These technological advances are poised to significantly increase the use of wearable injectors.

Key Growth Drivers

The primary factors driving market expansion include the rising prevalence of chronic diseases, a growing preference for home healthcare, and innovative breakthroughs including miniaturization and digital health platform integration. Such developments encourage self-administration and lessen the need for frequent hospital visits.

Challenges and Barriers

However, challenges persist, such as high development costs, particularly in emerging markets, and stringent regulatory hurdles that complicate device approval. Patient-related barriers, such as limited training and comfort concerns, also impede widespread adoption.

Market Insights

Market Segmentation

The market is segmented by device type, automation level, usability, therapeutic area, and geographical region. Notable segments include:

The wearable injectors market is poised for robust expansion, driven by the need for patient-centric solutions in chronic disease management. North America leads the market, with increased investment in healthcare infrastructure and innovation. As this sector evolves, stakeholders can expect enhanced market opportunities, driven by technological advancements and an increasing focus on home-based care models.

Key Attributes

A selection of companies mentioned in this report includes, but is not limited to:

For more information about this report visit https://www.researchandmarkets.com/r/6ihckd

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment